Walking the Tightrope: Chronic Pain and Substance Abuse

References 

1. Drug Enforcement Agency  . Promoting Pain Relief and Preventing Abuse of Pain Medications: A Critical Balancing Act. Joint Statement of DEA and 21 Health Organizations . Available at: www.aacpi.org/regulatory/consensus.pdf 2001; Accessed January 23, 2008.
2. Federation of State Medical Boards of the United States (FSMB)  . May 2004. Model Policy for the use of Controlled Substances for the Treatment of Pain . Available at: www.fsmb.org/pdf/2004_grpol_Controlled_Substances.pdf Accessed January 23, 2008;
3. Shurman J , Sack J , Shurman G , et al.   Share the risk model . Pract Pain Manage . 2006;6(5):10–18
4. Stacey BR . Management of peripheral neuropathic pain . Am J Phys Med Rehabil . 2005;84(Suppl 3):S4–S16
   • MEDLINE
5. Jackson KC . Pharmacotherapy for neuropathic pain . Pain Pract . 2006;6(1):27–33
   • CrossRef
6. Katz NP , Adams EH , et al.   Challenges in the development of prescription opioid abuse-deterrent formulations . Clin J Pain . 2007;31:648–660 8,
7. Portenoy RD , Payn R . Acute and chronic pain . In:  Lowinson JH ,  Ruiz P ,  Millman RB editor. Comprehensive textbook of substance abuse . 3rd ed.. Baltimore: Williams and Wilkins; 1997;p. 564; Table 57
8. Gourlay D , Heit H . Universal precautions in pain medicine: the treatment of chronic pain with or without the disease of addiction . Medscape Neurol Neurosurg . 2005;7(1): Posted April 28, 2005.
9. Brown RL , et al.   A two-item conjoint screen for alcohol and other drug problems . J Am Board Fam Physicians . 2001;14(2):95–104
10. Sleepiness Scale . Available at: www.cdha.nshealth.ca/sleeplab/epworthSleepinessScale.pdf Accessed November 2007.
11. Compton P . The role of urine toxicology in chronic opioid analgesic therapy . Pain Manage Nurs . 2007;8(4):166–172
12. Reisfield G , et al.   Opiates and opioids: what a difference a name makes . J Opioid Manage . 2007;3(4):179–180